CHAPEL HILL, N.C., May 31, 2011 /PRNewswire/ -- Cempra Pharmaceuticals Inc. today announced that Prabhavathi
Fernandes, president and chief executive officer, will present at the Jefferies 2011 Global Healthcare Conference at 1:30 p.m. EDT, June 6, 2011, at the Grand Hyatt in New
About Cempra Pharmaceuticals
Founded in 2006, Cempra Pharmaceuticals is a privately held, clinical-stage pharmaceutical company focused on developing antibacterials to address critical medical needs. Two lead products, both in late-stage clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in the hospital and in the community. Cempra is well-funded and is committed to developing commercially and medically differentiated and novel products that reduce development risk and provide a high financial return. The company is also utilizing its proprietary compound library and chemistry technology to develop novel macrolides without antibacterial activity for non-antibiotic uses such as COPD, chronic inflammatory and GI disorders. Additional information about Cempra can be found at www.cempra.com.
Media Contacts:Robert E. Flamm, Ph.D.Russo Partners LLC(212) 845-4226 Robert.firstname.lastname@example.org
Tony Russo, Ph.D.Russo Partners LLC(212) 845-4251Tony.email@example.com
SOURCE Cempra Pharmaceuticals Inc.
Subscribe to our Free Newsletters!
Cachexia refers to severe muscle and fat loss, anorexia and marked weight loss due to an underlying ...
Exotropia or outward eye deviation is a form of squint. Proper evaluation and timely intervention ...
Glaucoma is a group of disorders involving the optic nerve, often associated with a rise in ...View All